| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABO blood group influences risk of venous thromboembolism and myocardial infarction
|
Pang, Hui
|
|
|
50 |
2 |
p. 430-438
|
artikel
|
| 2 |
Antithrombotic therapy for atrial fibrillation with stable coronary artery disease: a meta-analysis of randomized controlled trials
|
Kheiri, Babikir
|
|
|
50 |
2 |
p. 395-398
|
artikel
|
| 3 |
An unusual presentation of Idiopathic hypereosinophilic syndrome
|
Chua, Chun En
|
|
|
50 |
2 |
p. 473-476
|
artikel
|
| 4 |
Baseline thrombocytopenia in women with coronary heart disease increases incident acute coronary syndrome: insights from national inpatient database
|
Sharma, Sharan P.
|
|
|
50 |
2 |
p. 462-467
|
artikel
|
| 5 |
Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials
|
Verdoia, Monica
|
|
|
50 |
2 |
p. 337-354
|
artikel
|
| 6 |
Blood type association with bleeding outcomes at delivery in a large multi-center study
|
Bade, Najeebah A.
|
|
|
50 |
2 |
p. 439-445
|
artikel
|
| 7 |
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE
|
Weitz, Jeffrey I.
|
|
|
50 |
2 |
p. 267-277
|
artikel
|
| 8 |
Comparison of 2013 and 2009 versions of Caprini risk assessment models for predicting VTE in Chinese cancer patients: a retrospective study
|
Shang, Mei-Mei
|
|
|
50 |
2 |
p. 446-451
|
artikel
|
| 9 |
Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit
|
White, D.
|
|
|
50 |
2 |
p. 478
|
artikel
|
| 10 |
Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines
|
Porfidia, Angelo
|
|
|
50 |
2 |
p. 477
|
artikel
|
| 11 |
Deep vein thrombosis: a less noticed complication in hematologic malignancies and immunologic disorders
|
Alipanahzadeh, Hassan
|
|
|
50 |
2 |
p. 318-329
|
artikel
|
| 12 |
Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients
|
Betoule, Anna
|
|
|
50 |
2 |
p. 302-304
|
artikel
|
| 13 |
Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes
|
Davis, Kyle A.
|
|
|
50 |
2 |
p. 457-461
|
artikel
|
| 14 |
Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials
|
Brunetti, Natale Daniele
|
|
|
50 |
2 |
p. 305-310
|
artikel
|
| 15 |
Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
|
Cirillo, Plinio
|
|
|
50 |
2 |
p. 468-472
|
artikel
|
| 16 |
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
|
Pavoni, Vittorio
|
|
|
50 |
2 |
p. 281-286
|
artikel
|
| 17 |
Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia
|
Fan, Bingwen Eugene
|
|
|
50 |
2 |
p. 292-297
|
artikel
|
| 18 |
Heparin resistance in COVID-19 patients in the intensive care unit
|
White, D.
|
|
|
50 |
2 |
p. 287-291
|
artikel
|
| 19 |
Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy
|
Smith, Kristin R.
|
|
|
50 |
2 |
p. 452-456
|
artikel
|
| 20 |
Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States
|
Guo, J. D.
|
|
|
50 |
2 |
p. 386-394
|
artikel
|
| 21 |
Management of periprocedural anticoagulant therapy: a novel individualized approach—a transeusophageal echocardiographic study
|
Durmaz, Eser
|
|
|
50 |
2 |
p. 408-415
|
artikel
|
| 22 |
Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban
|
Ueno, Ei-ichi
|
|
|
50 |
2 |
p. 371-379
|
artikel
|
| 23 |
Non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis
|
Zhou, Yunguo
|
|
|
50 |
2 |
p. 311-317
|
artikel
|
| 24 |
Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation
|
Yip, Christina
|
|
|
50 |
2 |
p. 421-429
|
artikel
|
| 25 |
Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy
|
Belen-Apak, F. Burcu
|
|
|
50 |
2 |
p. 278-280
|
artikel
|
| 26 |
Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience
|
Filopei, Jason
|
|
|
50 |
2 |
p. 399-407
|
artikel
|
| 27 |
Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-α induced nuclear factor-κappa B signaling pathway in rats
|
Al-Harbi, Naif O.
|
|
|
50 |
2 |
p. 361-370
|
artikel
|
| 28 |
Safety outcomes of apixaban in patients with nonvalvular atrial fibrillation and severe renal impairment
|
Jones, Maura J.
|
|
|
50 |
2 |
p. 330-336
|
artikel
|
| 29 |
Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life
|
Tantawy, Azza A.
|
|
|
50 |
2 |
p. 258-266
|
artikel
|
| 30 |
Soluble platelet endothelial cell adhesion molecule 1 (sPECAM-1) improves diagnostic accuracy of D-Dimer in patients with suspected deep vein thrombosis (DVT)
|
Kellermair, Joerg
|
|
|
50 |
2 |
p. 380-385
|
artikel
|
| 31 |
Superficial venous thrombosis: is it as benign as we think?
|
Lui, B.
|
|
|
50 |
2 |
p. 416-420
|
artikel
|
| 32 |
The association between treatment with heparin and survival in patients with Covid-19
|
Ayerbe, Luis
|
|
|
50 |
2 |
p. 298-301
|
artikel
|
| 33 |
The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials
|
Yu, Xianbin
|
|
|
50 |
2 |
p. 243-257
|
artikel
|
| 34 |
Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience
|
Porfidia, Angelo
|
|
|
50 |
2 |
p. 355-360
|
artikel
|
Tijdschrift beschrijving